Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome

• Main Authors: Ruifeng Tian (Author), Jinjie Yang (Author), Xiaoming Wang (Author), Shuaiyang Liu (Author), Ruixiang Dong (Author), Zhenya Wang (Author), Zifeng Yang (Author), Yingping Zhang (Author), Zhiwei Cai (Author), Hailong Yang (Author), Yufeng Hu (Author), Zhi-Gang She (Author), Hongliang Li (Author), Junjie Zhou (Author), Xiao-Jing Zhang (Author)
• Format: Book
• Published: BMC, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Non-alcoholic fatty liver (NAFLD) and its related metabolic syndrome have become major threats to human health, but there is still a need for effective and safe drugs to treat these conditions. Here we aimed to identify potential drug candidates for NAFLD and the underlying molec...